Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration

Clinical trial NCT02707458 · COMPLETED

Trial details

NCT number: NCT02707458
Sponsor: Douglas Mental Health University Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Dementia of the Alzheimer Type Age-related Cognitive Decline Mild Cognitive Impairment Due to Alzheimer Disease

Start date: 2016-04-01
Primary completion: 2017-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.